MT-ND2
NADH-ubiquinone oxidoreductase chain 2
Also known as: MTND2, NAD2, ND2, NU2M_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P03891
- Gene
- MT-ND2
- Ensembl
- ENSG00000198763
- Chromosome
- MT
- Canonical length
- 347 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
OverviewNCBI Gene
Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Located in mitochondrial inner membrane. Part of respiratory chain complex I. Implicated in Leber hereditary optic neuropathy; multiple sclerosis; myocardial infarction; neurodegenerative disease (multiple); and urinary bladder cancer. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
347 residues, UniProt reviewed canonical sequence.
>P03891|MT-ND2
1 MNPLAQPVIY STIFAGTLIT ALSSHWFFTW VGLEMNMLAF IPVLTKKMNP RSTEAAIKYF
61 LTQATASMIL LMAILFNNML SGQWTMTNTT NQYSSLMIMM AMAMKLGMAP FHFWVPEVTQ
121 GTPLTSGLLL LTWQKLAPIS IMYQISPSLN VSLLLTLSIL SIMAGSWGGL NQTQLRKILA
181 YSSITHMGWM MAVLPYNPNM TILNLTIYII LTTTAFLLLN LNSSTTTLLL SRTWNKLTWL
241 TPLIPSTLLS LGGLPPLTGF LPKWAIIEEF TKNNSLIIPT IMATITLLNL YFYLRLIYST
301 SITLLPMSNN VKMKWQFEHT KPTPFLPTLI ALTTLLLPIS PFMLMILLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MT-ND2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 130,853 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 130,853 nTPM
- basal ganglia: 107,283 nTPM
- hippocampal formation: 73,212 nTPM
- midbrain: 70,739 nTPM
- amygdala: 68,050 nTPM
- hypothalamus: 59,028 nTPM
Single-cell type
- enterocytes: 32,456 nCPM
- colonocytes: 18,264 nCPM
- goblet cells: 16,908 nCPM
- hepatocytes: 16,746 nCPM
- paneth cells: 15,547 nCPM
- enteric stem cells: 14,080 nCPM
Immune cell
- basophil: 16,898 nTPM
- eosinophil: 2,716 nTPM
- neutrophil: 2,365 nTPM
- classical monocyte: 1,660 nTPM
- naive B-cell: 1,632 nTPM
- memory B-cell: 1,574 nTPM
Brain region
- pons: 58,856 nTPM
- medulla oblongata: 51,541 nTPM
- cerebral cortex: 51,500 nTPM
- midbrain: 46,129 nTPM
- thalamus: 40,914 nTPM
- basal ganglia: 39,579 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MT-ND2.
Disease | AllUniProt
Conditions MT-ND2 is implicated in, by any mechanism.
- Leber hereditary optic neuropathy (LHON) MIM:535000
- Alzheimer disease mitochondrial (AD-MT) MIM:502500
- Leigh syndrome (LS) MIM:256000
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 186 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
OntologyGO
Biological processes
- aerobic respiration
- mitochondrial electron transport, NADH to ubiquinone
- mitochondrial respiratory chain complex I assembly
- proton motive force-driven mitochondrial ATP synthesis
- reactive oxygen species metabolic process
- response to hypoxia
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- NADH:quinone oxidoreductase/Mrp antiporter, transmembrane domain
- NADH:quinone oxidoreductase/Mrp antiporter, TM
- NADH:ubiquinone oxidoreductase, chain 2
- NADH dehydrogenase subunit 2, C-terminal
- Complex I Subunit 2
- NADH dehydrogenase subunit 2 C-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MT-ND2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MT-ND2 as an antibody target. Whether an autoantibody or antibody against MT-ND2 could matter depends on whether native MT-ND2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MT-ND2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MT-ND2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...